AAAAAA
Results: 1-25/27
Authors:
Ballinger, JR
Citation: Jr. Ballinger, Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein, CANC BIO R, 16(1), 2001, pp. 1-7
Authors:
Zhang, XG
Melo, T
Rauth, AM
Ballinger, JR
Citation: Xg. Zhang et al., Cellular accumulation and retention of the technetium-99m-labelled hypoxiamarkers BRU59-21 and butylene amine oxime, NUCL MED BI, 28(8), 2001, pp. 949-957
Authors:
Ballinger, JR
Citation: Jr. Ballinger, Tc-99m-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo, J CLIN PHAR, 2001, pp. 39S-47S
Authors:
Li, YQ
Ballinger, JR
Nordal, RA
Su, ZF
Wong, CS
Citation: Yq. Li et al., Hypoxia in radiation-induced blood-spinal cord barrier breakdown, CANCER RES, 61(8), 2001, pp. 3348-3354
Authors:
Muzzammil, T
Moore, MJ
Hedley, D
Ballinger, JR
Citation: T. Muzzammil et al., Comparison of Tc-99m-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function, BR J CANC, 84(3), 2001, pp. 367-373
Authors:
Ballinger, JR
Citation: Jr. Ballinger, Imaging hypoxia in tumors, SEM NUC MED, 31(4), 2001, pp. 321-329
Authors:
Muzzammil, T
Moore, MJ
Ballinger, JR
Citation: T. Muzzammil et al., In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors, CANC BIO R, 15(4), 2000, pp. 339-346
Authors:
Su, ZF
Ballinger, JR
Rauth, AM
Abrams, DN
Billinghurst, MW
Citation: Zf. Su et al., A novel amine-dioxime chelator for technetium-99m: Synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells, BIOCONJ CHE, 11(5), 2000, pp. 652-663
Authors:
Zhang, XG
Su, ZF
Ballinger, JR
Rauth, AM
Pollak, A
Thornback, JR
Citation: Xg. Zhang et al., Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: Effect of lipophilicity, BIOCONJ CHE, 11(3), 2000, pp. 401-407
Authors:
Kim, M
Gronda, MV
Messner, HA
Ballinger, JR
Citation: M. Kim et al., Accumulation of sestamibi in lymphoma cell lines in vitro, LEUK LYMPH, 38(5-6), 2000, pp. 599-603
Authors:
Dunn-Dufault, R
Pollak, A
Fitzgerald, J
Thornback, JR
Ballinger, JR
Citation: R. Dunn-dufault et al., A solid-phase technique for preparation of no-carrier-added technetium-99mradiopharmaceuticals: Application to the streptavidin/biotin system, NUCL MED BI, 27(8), 2000, pp. 803-807
Authors:
Boxen, I
McCready, D
Ballinger, JR
Citation: I. Boxen et al., Sentinel nodes - Interval nodes, lymphatic lakes, and accurate sentinel node identification, CLIN NUCL M, 25(3), 2000, pp. 235-236
Authors:
Utsunomiya, K
Ballinger, JR
Piquette-Miller, M
Rauth, AM
Tang, W
Su, ZF
Ichise, M
Citation: K. Utsunomiya et al., Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line, EUR J NUCL, 27(12), 2000, pp. 1786-1792
Authors:
Ballinger, JR
Li, JH
Citation: Jr. Ballinger et Jh. Li, Sestamibi accumulation in human nasopharyngeal carcinoma cell lines in vitro, ANTICANC R, 20(2A), 2000, pp. 677-679
Authors:
Ballinger, JR
Citation: Jr. Ballinger, Local and distant effects of radiotherapy on FDG accumulation in bone marrow - Invited commentary, J NUCL MED, 41(12), 2000, pp. 2036-2037
Authors:
Melo, T
Duncan, J
Ballinger, JR
Rauth, AM
Citation: T. Melo et al., BRU59-21, a second-generation Tc-99m-labeled 2-nitroimidazole for imaging hypoxia in tumors, J NUCL MED, 41(1), 2000, pp. 169-176
Authors:
Back, MR
Kluess, HA
Huber, TS
Stopka, CB
Scott, KN
Ballinger, JR
Welsch, MA
Bruner, AP
Lyles, T
Harward, TRS
Seeger, JM
Citation: Mr. Back et al., Evaluation of skeletal muscle metabolic responses following exercise training in patients with intermittent claudication, VASC SURG, 34(4), 2000, pp. 345-359
Authors:
Liu, Z
Wu, XY
Ballinger, JR
Bendayan, R
Citation: Z. Liu et al., Synthesis and characterization of surface-hydrophobic ion-exchange microspheres and the effect of coating on drug release rate, J PHARM SCI, 89(6), 2000, pp. 807-817
Authors:
Tunggal, JK
Melo, T
Ballinger, JR
Tannock, IF
Citation: Jk. Tunggal et al., The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers, INT J CANC, 86(1), 2000, pp. 101-107
Authors:
Melo, T
Ballinger, JR
Rauth, AM
Citation: T. Melo et al., Role of NADPH : Cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxia, BIOCH PHARM, 60(5), 2000, pp. 625-634
Authors:
Dunn-Dufault, R
Pollak, A
Thornback, JR
Ballinger, JR
Citation: R. Dunn-dufault et al., Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology, BIOCONJ CHE, 10(5), 1999, pp. 832-837
Authors:
Su, ZF
Zhang, XG
Ballinger, JR
Rauth, AM
Pollak, A
Thornback, JR
Citation: Zf. Su et al., Synthesis and evaluation of two technetium-99m-labeled peptidic e-nitroimidazoles for imaging hypoxia, BIOCONJ CHE, 10(5), 1999, pp. 897-904
Authors:
Boxen, I
McCready, D
Ballinger, JR
Citation: I. Boxen et al., Sentinel node detection and definition may depend on the imaging agent andtiming, CLIN NUCL M, 24(6), 1999, pp. 390-394
Authors:
Ichise, M
Kim, YJ
Erami, SS
Ballinger, JR
Vines, D
Tanaka, F
Lang, AE
Citation: M. Ichise et al., Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of I-123-beta-CIT SPECT data, J NUCL MED, 40(4), 1999, pp. 530-538
Authors:
Muzzammil, T
Ballinger, JR
Moore, MJ
Citation: T. Muzzammil et al., Tc-99(m)-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer, NUCL MED C, 20(2), 1999, pp. 115-122